Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment.
about
Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Nanomedicines for renal disease: current status and future applicationsCitrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability.
P2860
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@ast
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@en
type
label
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@ast
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@en
prefLabel
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@ast
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and pharmacod ...... r moderate hepatic impairment.
@en
P2093
Ashley Milton
Dennis Noe
Jaime Mertz
Kambiz Farbakhsh
Karthik Venkatakrishnan
Thomas Marbury
P2860
P304
P356
10.1111/BCP.12261
P407
P577
2014-06-01T00:00:00Z